نتایج جستجو برای: ctla

تعداد نتایج: 3441  

Journal: :Journal of veterinary science 2000
I S Choi H S Yoo E W Collisson

It is known that CD28, a positive costimulatory receptor, plays a very important role in inducing the optimal stimulation of T lymphocytes. CTLA-4 (CD152), however, acts as a negative regulator in T lymphocyte activation. The effect of an feline immunodeficiency virus (FIV) infection on the expression of feline CD28 and CTLA-4 was studied with FIV-infected and uninfected peripheral blood mononu...

2011
Vijay K. Kuchroo Arlene H. Sharpe Mohamed Oukka Linda S. Wicker Francisco J. Quintana Alison M. Paterson Sue M. Liu Andrew P. R. Sutherland Zheng Zhang Daniel B. Rainbow

CTLA-4 is a potent inhibitor of T cell activation, primarily upon binding to its costimulatory ligands (B7.1 and B7.2) expressed on APCs. However, variants of CTLA-4 can also function independently of B7 molecules. 1/4CTLA-4 is a highly conserved isoform encoded by exons 1 and 4 of the Ctla4 gene that lacks the ligand-binding and the transmembrane domains, and as yet, its function is not known....

  Background: Both genetic and environmental factors are important in pathogenesis of diabetes. Non HLA (Human Leukocyte Antigen) genes such as INS-VNTR and CTLA-4 in addition of HLA genes have influence on genetic susceptibility for diabetes mellitus. In this study the association of +49 A/G CTLA-4 and -23 A/T INS-VNTR polymorphisms with diabetes and their association with islet auto...

ژورنال: طب جنوب 2013
بوالخیر, علیرضا, جابری‌پور, منصوره, حبیب‌آگهی, مجتبی, حسینی, احمد, خادمی, بیژن, قادری, عباس,

زمینه: سلول‌های Treg قوی‌ترین منع‌کننده‌ی ایمنی ضدتورمورال هستند و بیان CTLA-4 برای عملکرد سلول‌های تنظیم‌گرT FOXP3+ طبیعی مادام که این ملکول را بیان می‌کنند، ضروری می‌باشد. اینترلوکین 10 نیز به‌عنوان یک عامل منع کننده‌ی ایمنی، در عرضه آنتی‌ژن به‌صورت مؤثر عمل کرده و فعالیت سلول‌هایT اختصاصی تومورال را با مانع یا محدودیت توأم می‌کند. هدف ازاین بررسی مقایسه بیان و کمیت بیان ژن‌های FOXP3 و CTLA-4...

Journal: :Journal of immunology 2015
Tie Zheng Hou Omar S Qureshi Chun Jing Wang Jennifer Baker Stephen P Young Lucy S K Walker David M Sansom

Manipulation of the CD28/CTLA-4 pathway is at the heart of a number of immunomodulatory approaches used in both autoimmunity and cancer. Although it is clear that CTLA-4 is a critical regulator of T cell responses, the immunological contexts in which CTLA-4 controls immune responses are not well defined. In this study, we show that whereas CD80/CD86-dependent activation of resting human T cells...

2014
Matthew C. Banton Kerry L. Inder Elke Valk Christopher E. Rudd Helga Schneider

Despite playing a central role in tolerance, little is known regarding the mechanism by which intracellular CTLA-4 is shuttled from the trans-Golgi network to the surfaces of T cells. In this context, Ras-related GTPase Rab8 plays an important role in the intracellular transport, while we have previously shown that CTLA-4 binds to the immune cell adaptor TRIM in T cells. In this study, we demon...

Journal: :The Journal of Experimental Medicine 2001
Margarita Martin Helga Schneider Abdallah Azouz Christopher E. Rudd

Coreceptors CD28 and cytotoxic T lymphocyte antigen (CTLA)-4 have opposing effects on TcR/CD3 activation of T cells. While CD28 enhances and CTLA-4 inhibits activation, the underlying molecular basis of these effects has yet to be established. In this context, ganglioside and cholesterol enriched membrane microdomains (rafts, GEMs) serve as centers of signaling in T cells. Although CD28 can pro...

2017
Xi Chen Qianqian Shao Shengnan Hao Zhonghua Zhao Yang Wang Xiaofan Guo Ying He Wenjuan Gao Haiting Mao

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), a potent immunoregulatory molecule, can down-regulate T-cell activation and inhibit anti-tumor immune response. This study showed that LPS-stimulated human dendritic cells (DCs) decreased the expression of HLA-DR, CD83 and costimulatory molecules (CD40, CD80 and CD86) following coculturing with CTLA-4+ breast cancer cells. Moreover, the supp...

Journal: :JCI insight 2018
Danya Liu I Raul Badell Mandy L Ford

Memory T cells pose a significant problem to successful therapeutic control of unwanted immune responses during autoimmunity and transplantation, as they are differentially controlled by cosignaling receptors such as CD28 and CTLA-4. Treatment with abatacept and belatacept impede CD28 signaling by binding to CD80 and CD86, but they also have the unintended consequence of blocking the ligands fo...

Journal: :Science 2015
Marie Vétizou Jonathan M Pitt Romain Daillère Patricia Lepage Nadine Waldschmitt Caroline Flament Sylvie Rusakiewicz Bertrand Routy Maria P Roberti Connie P M Duong Vichnou Poirier-Colame Antoine Roux Sonia Becharef Silvia Formenti Encouse Golden Sascha Cording Gerard Eberl Andreas Schlitzer Florent Ginhoux Sridhar Mani Takahiro Yamazaki Nicolas Jacquelot David P Enot Marion Bérard Jérôme Nigou Paule Opolon Alexander Eggermont Paul-Louis Woerther Elisabeth Chachaty Nathalie Chaput Caroline Robert Christina Mateus Guido Kroemer Didier Raoult Ivo Gomperts Boneca Franck Carbonnel Mathias Chamaillard Laurence Zitvogel

Antibodies targeting CTLA-4 have been successfully used as cancer immunotherapy. We find that the antitumor effects of CTLA-4 blockade depend on distinct Bacteroides species. In mice and patients, T cell responses specific for B. thetaiotaomicron or B. fragilis were associated with the efficacy of CTLA-4 blockade. Tumors in antibiotic-treated or germ-free mice did not respond to CTLA blockade. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید